- 592 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Heparin-Induced Thrombocytopenia
About this book
Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this cond
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Heparin-Induced Thrombocytopenia by Theodore Warkentin,Andreas Greinacher in PDF and/or ePUB format, as well as other popular books in Medicine & Clinical Medicine. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover Page
- Halftitle Page
- Title Page
- Copyright Page
- Dedication Page
- Contents
- Contributors
- Preface
- 1 History of heparin-induced thrombocytopenia
- 2 Clinical picture of heparin-induced thrombocytopenia
- 3 Differential diagnosis of heparin-induced thrombocytopenia and scoring systems
- 4 Frequency of heparin-induced thrombocytopenia
- 5 Nonimmune heparin-platelet interactions: Implications for the pathogenesis of heparin-induced thrombocytopenia
- 6 Role of heparin-dependent antigens in immune heparin-induced thrombocytopenia
- 7 Role of sulfated polysaccharides and other polyanions in the pathogenesis of heparin-induced thrombocytopenia
- 8 Platelet and leukocyte Fcy receptors in heparin-induced thrombocytopenia
- 9 Cellular and molecular immunopathogenesis of heparin-induced thrombocytopenia
- 10 Murine models of heparin-induced thrombocytopenia
- 11 Laboratory testing for heparin-induced thrombocytopenia
- 12 Treatment of heparin-induced thrombocytopenia: An overview
- 13 Argatroban therapy in heparin-induced thrombocytopenia
- 14 Recombinant hirudin for the treatment of heparin-induced thrombocytopenia
- 15 Bivalirudin for the treatment of heparin-induced thrombocytopenia
- 16 Danaparoid for the treatment of heparin-induced thrombocytopenia
- 17 Fondaparinux and other emerging anticoagulants to treat heparin-induced thrombocytopenia
- 18 Hemodialysis in heparin-induced thrombocytopenia
- 19 Management of intraoperative anticoagulation in patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery
- 20 Heparin-coated intravascular devices and heparin-induced thrombocytopenia
- 21 Heparin-induced thrombocytopenia in children
- 22 A clinician’s perspective on heparin-induced thrombocytopenia: Paradoxes, myths, and continuing challenges
- Appendix
- Index